Does aging change docosahexaenoic acid homeostasis? Implications for the challenge to cognitive health in the elderly

OCL - Oleagineux Corps Gras Lipides

Volumn 18, Issue 4, 2011, Pages 175-180

  Castellano, Christian Alexandre ^a   Raphael Chouinard Watkins ^a   Brenna, J Tom ^b   Meyer, Barbara J ^c   Cunnane, Stephen C ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b Department of Molecular Biology and Genetics   (United States)

^c UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Aging; Cognitive decline; Dietary; Docosahexaenoic acid; Omega 3 fatty acid

Indexed keywords

EID: 80053350219     PISSN: 12588210     EISSN: 1950697X     Source Type: Journal    
DOI: 10.1684/ocl.2011.0390     Document Type: Conference Paper

References (43)

1. Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 2006; 83: 1467S-76S. (Pubitemid 44713087)
2. Babin F, Abderrazik M, Favier F, et al. Differences between polyunsaturated fatty acid status of non-institutionalised elderly women and younger controls: A bioconversion defect can be suspected. Eur J Clin Nutr 1999; 53: 591-6. (Pubitemid 29396563)
3. Beydoun MA, Kaufman JS, Satia JA, Rosamond W, Folsom AR. Plasma n-3 fatty acids and the risk of cognitive decline in older adults: The atherosclerosis risk in communities study. Am J Clin Nutr 2007; 85: 1103-11. (Pubitemid 46557928)
4. Blonk MC, Bilo HJG, Nauta JJP, Popp-Snijders C, Mulder C, Donker AJM.Dose-response effects of fish-oil supplementation in healthy volunteers. Am J Clin Nutr 1990; 52: 120-7.
5. Buyken A, Flood V, Rochtchina E, Nestel P, Brand-Miller J, Mitchell P. Modifications in dietary fat quality are associated with chnages in serum lipids of older adults independently of lipid medication. J Nutr 2010; 140: 88-94.
6. Crowe FL, Skeaff CM, Green TJ, Gray AR. Serum n-3 long-chain PUFA differ by sex and age in a population-based survey of New Zealand adolescents and adults. Br J Nutr 2008; 99: 168-74. (Pubitemid 350286151)
7. Cunnane S, Nugent S, Roy M,et al. Brain fuel metabolism, aging, and Alzheimer's disease. Nutrition 2011; 27: 3-20.
8. Cunnane SC, Plourde M, Pifferi F, Bégin M, Féart C, Barberger-Gateau P. Fish, docosahexaenoic acid and Alzheimer's disease. Prog Lipid Res 2009; 48: 239-56.
9. Dangour AD, Allen E, Elbourne D, et al. Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: A randomized, double-blind, controlled trial. Am J Clin Nutr 2010; 91: 1725-32.
10. De Groot RHM, Van Boxtel MPJ, Schiepers OJG, Hornstra G, Jolles J. Age dependence of plasma phospholipid fatty acid levels: Potential role of linoleic acid in the age-associated increase in docosahexaenoic acid and eicosapentaenoic acid concentrations. Br J Nutr 2009; 102: 1058-64.
11. Dewailly E, Blanchet C, Gingras S, Lemieux S, Holub BJ. Fish consumption and blood lipids in three ethnic groups of Québec (Canada). Lipids 2003; 38: 359-65. (Pubitemid 36724292)
12. Dullemeijer C, Durga J, Brouwer IA, et al. n-3 Fatty acid proportions in plasma and cognitive performance in older adults. Am J Clin Nutr 2007; 86: 1479-85. (Pubitemid 350126254)
13. Fortier M, Tremblay-Mercier J, Plourde M, et al. Higher plasma n-3 fatty acid status in the moderately healthy elderly in southern Québec: Higher fish intake or aging-related change in n-3 fatty acid metabolism? Prostaglandins Leukotrienes and Essential Fatty Acids 2010; 82: 277-80.
14. Fotuhi M, Mohassel P, Yaffe K. Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: A complex association. Nat Clin Pract Neurol 2009; 5: 140-52.
15. Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T, et al. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol 2006; 63: 1402-8. (Pubitemid 44547551)
16. Hao Z, Wu B, Wang D, Liu M. Association between metabolic syndrome and cognitive decline: A systematic review of prospective population-based studies. Acta Neuropsychiatrica 2011; 23: 69-74.
17. Jolivalt C, Leininger-Muller B, Bertrand P, Herber R, Christen Y, Siest G. Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids. Free Radical Biology and Medicine 2000; 28: 129-40. (Pubitemid 30045581)
18. Kharrazi H, Vaisi-Raygani A, Rahimi Z, Tavilani H, Aminian M, Pourmotabbed T. Association between enzymatic and nonenzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease. Clin Biochem 2008; 41: 932-6.
19. Kris-Etherton PM, Grieger JA, Etherton TD. Dietary reference intakes for DHA and EPA. Prostaglandins Leukotrienes and Essential Fatty Acids 2009; 81: 99-104.
20. Leoni V. The effect of apolipoprotein e (ApoE) genotype on biomarkers of amyloidogenesis, tau pathology and neurodegeneration in Alzheimer's disease. Clin Chem Lab Med 2011; 49: 375-83.
21. Lopez LB, Kritz-Silverstein D, Barrett-Connor E. High dietary and plasma levels of the omega-3 fatty acid docosahexaenoic acid are associated with decreased dementia risk: The Rancho Bernardo study. J Nutr Health Aging 2010: 1-7.
22. Lucas M, Asselin G, Plourde M, Cunnane SC, Dewailly E, Dodin S.N-3 Fatty acid intake frommarinefoodproductsamongQuebecers: Comparison to worldwide recommendations. Public Health Nutrition 2010; 13: 63-70.
23. McCloy U, Ryan MA, Pencharz PB, Ross RJ, Cunnane SC.A comparison of the metabolism of eighteen-carbon 13C-unsaturated fatty acids in healthy women. J Lipid Res 2004; 45: 474-85. (Pubitemid 38337994)
24. Meyer B. Are we consuming enough long chain omega-3 polyunstaurated fatty acids for optimal health? Prostaglandins Leukotrienes and Essential Fatty Acids. 2011.
25. Meyer B, Mann N, Lewis J, Milligan G, Sinclair A, Howe P. Dietary intakes and food sources of omeag-6 and omega-3 polyunsaturated fatty acids. Lipids 2003; 38: 391-8. (Pubitemid 36724296)
26. Miyata M, Smith J. Apolipoprotein E allelespecific antioxidant activity and effects on cytotoxicity by oxidative insults and betaamyloid peptides. Nat Genet 1996; 14: 55-61. (Pubitemid 26301547)
27. Pifferi F, Jouin M, Alessandri JM, et al. N-3 long-chain fatty acids and regulation of glucose transport in two models of rat brain endothelial cells. Neurochem Int 2010; 56: 703-10.
28. Plourde M, Chouinard-Watkins R, Vandal M, et al. Plasma incorporation, apparent retroconversion and b-oxidation of 13C-docosahexaenoic acid in the elderly. Nutrition and Metabolism 2011; 8.
29. Plourde M, Vohl MC, Vandal M, Couture P, Lemieux S, Cunnane SC. Plasma n-3 fatty acid response to an n-3 fatty acid supplement is modulated by apoE 4 but not by the common PPAR- L162V polymorphism in men. Br J Nutr 2009 ; 102: 1121-4.
30. Quinn JF, Raman R, Thomas RG, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: A randomized trial. JAMA 2010; 304: 1903-11.
31. Ramassamy C, Averill D, Beffert U, et al. Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brain. Neurobiol Dis 2000; 7: 23-37. (Pubitemid 30141817)
32. Sanders TAB, Hinds A, Pereira CC. Influence of n-3 fatty acids on blood lipids in normal subjects. J Intern Med, Supplement 1989; 225: 99-104. (Pubitemid 19191753)
33. Sfar S, Laporte F, Braham H, Jawed A, Amor S, Kerkeni A. Influence of dietary habits, age and gender on plasma fatty acids levels in a population of healthy Tunisian subjects. Experimental Gerontology 2010; 45: 719-25.
34. Song F, Poljak A, Smythe GA, Sachdev P. Plasma biomarkers for mild cognitive impairment and Alzheimer's disease. Brain Res Rev 2009; 61: 69-80.
35. Sublette ME, Bosetti F, Demar JC, et al. Plasma free polyunsaturated fatty acid levels are associated with symptom severity in acute mania. Bipolar Disorders 2007; 9: 759-65. (Pubitemid 350042412)
36. Sun, Q, Ma J, Campos H, Hankinson SE, Hu FB. Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am J Clin Nutr 2007; 86: 74-81. (Pubitemid 47041595)
37. Swierk M, Williams P, Wilcox J, Russell K, Meyer B. Validation of an Australian Electronic Food Frequency Questionnaire to Measure Polyunsaturated Fatty Acid Intake. Nutrition 2011; 27: 641-6.
38. Van De Rest O, Geleijnse JM, Kok FJ, et al. Effect of fish oil on cognitive performance in older subjects: A randomized, controlled trial. Neurology 2008; 71: 430-8.
39. Vandal M, Freemantle E, Tremblay-Mercier J, et al. Plasma omega-3 fatty acid response to a fish oil supplement in the healthy elderly. Lipids 2008; 43: 1085-9.
40. Whalley LJ, Deary IJ, Starr JM, et al. n-3 Fatty acid erythrocyte membrane content, APOE e4, and cognitive variation: An observational follow-up study in late adulthood. Am J Clin Nutr 2008; 87: 449-54. (Pubitemid 351226084)
41. Whitehouse P, George D, D'Alton S. Describing the Dying Days of "Alzheimer's Disease". J Alzheimer's Dis 2011; 24: 11-3.
42. Yanagisawa N, Shimada K, Miyazaki T, et al. Polyunsaturated fatty acid levels of serum and red blood cells in apparently healthy Japanese subjects living in an Urban Area. Journal of Atherosclerosis and Thrombosis 2010; 17: 285-94.
43. Yurko-Mauro K, McCarthy D, Rom D, et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimer's and Dementia 2010; 6: 456-64.